• Je něco špatně v tomto záznamu ?

Characterisation of grids of point detectors in maximum skin dose measurement in fluoroscopically-guided interventional procedures

J. Dabin, A. Negri, J. Farah, O. Ciraj-Bjelac, I. Clairand, C. De Angelis, J. Domienik, H. Jarvinen, R. Kopec, M. Majer, F. Malchair, L. Novák, T. Siiskonen, F. Vanhavere, A. Trianni, Ž. Knežević,

. 2015 ; 31 (8) : 1112-7. [pub] 20151004

Jazyk angličtina Země Itálie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17000974

PURPOSE: Point detectors are frequently used to measure patient's maximum skin dose (MSD) in fluoroscopically-guided interventional procedures (IP). However, their performance and ability to detect the actual MSD are rarely evaluated. The present study investigates the sampling uncertainty associated with the use of grids of point detectors to measure MSD in IP. METHOD: Chemoembolisation of the liver (CE), percutaneous coronary intervention (PCI) and neuroembolisation (NE) procedures were studied. Spatial dose distributions were measured with XR-RV3 Gafchromic(®) films for 176 procedures. These distributions were used to simulate measurements performed using grids of detectors such as thermoluminescence detectors, with detector spacing from 1.4 up to 10 cm. RESULTS: The sampling uncertainty was the highest in PCI and NE procedures. With 40 detectors covering the film area (36 cm × 44 cm), the maximum dose would be on average 86% and 63% of the MSD measured with Gafchromic(®) films in CE and PCI procedures, respectively. In NE procedures, with 27 detectors covering the film area (14 cm × 35 cm), the maximum dose measured would be on average 82% of the MSD obtained with the Gafchromic(®) films. CONCLUSION: Thermoluminescence detectors show good energy and dose response in clinical beam qualities. However the poor spatial resolution of such point-like dosimeters may far outweigh their good dosimetric properties. The uncertainty from the sampling procedure should be estimated when point detectors are used in IP because it may lead to strong underestimation of the MSD.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17000974
003      
CZ-PrNML
005      
20170119101745.0
007      
ta
008      
170103s2015 it f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ejmp.2015.08.006 $2 doi
024    7_
$a 10.1016/j.ejmp.2015.08.006 $2 doi
035    __
$a (PubMed)26439858
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a it
100    1_
$a Dabin, J $u Belgian Nuclear Research Centre (SCK-CEN), Boeretang 200, BE-2400 Mol, Belgium. Electronic address: jeremie.dabin@sckcen.be.
245    10
$a Characterisation of grids of point detectors in maximum skin dose measurement in fluoroscopically-guided interventional procedures / $c J. Dabin, A. Negri, J. Farah, O. Ciraj-Bjelac, I. Clairand, C. De Angelis, J. Domienik, H. Jarvinen, R. Kopec, M. Majer, F. Malchair, L. Novák, T. Siiskonen, F. Vanhavere, A. Trianni, Ž. Knežević,
520    9_
$a PURPOSE: Point detectors are frequently used to measure patient's maximum skin dose (MSD) in fluoroscopically-guided interventional procedures (IP). However, their performance and ability to detect the actual MSD are rarely evaluated. The present study investigates the sampling uncertainty associated with the use of grids of point detectors to measure MSD in IP. METHOD: Chemoembolisation of the liver (CE), percutaneous coronary intervention (PCI) and neuroembolisation (NE) procedures were studied. Spatial dose distributions were measured with XR-RV3 Gafchromic(®) films for 176 procedures. These distributions were used to simulate measurements performed using grids of detectors such as thermoluminescence detectors, with detector spacing from 1.4 up to 10 cm. RESULTS: The sampling uncertainty was the highest in PCI and NE procedures. With 40 detectors covering the film area (36 cm × 44 cm), the maximum dose would be on average 86% and 63% of the MSD measured with Gafchromic(®) films in CE and PCI procedures, respectively. In NE procedures, with 27 detectors covering the film area (14 cm × 35 cm), the maximum dose measured would be on average 82% of the MSD obtained with the Gafchromic(®) films. CONCLUSION: Thermoluminescence detectors show good energy and dose response in clinical beam qualities. However the poor spatial resolution of such point-like dosimeters may far outweigh their good dosimetric properties. The uncertainty from the sampling procedure should be estimated when point detectors are used in IP because it may lead to strong underestimation of the MSD.
650    _2
$a chemoembolizace $x metody $7 D016461
650    _2
$a fluoroskopie $7 D005471
650    _2
$a koronární angioplastika $x metody $7 D062645
650    12
$a dávka záření $7 D011829
650    _2
$a kůže $x účinky záření $7 D012867
650    _2
$a termoluminiscenční dozimetrie $7 D013819
650    _2
$a nejistota $7 D035501
655    _2
$a časopisecké články $7 D016428
700    1_
$a Negri, A $u Medical Physics Department,Veneto Institute of Oncology IOV-IRCCS, Via Gattamelata 64, 35128 Padova, Italy.
700    1_
$a Farah, J $u Institut de Radioprotection et de Sûreté Nucléaire (IRSN), BP17, 92262 Fontenay-aux-Roses Cedex, France.
700    1_
$a Ciraj-Bjelac, O $u VINCA Institute of Nuclear Sciences (VINCA), University of Belgrade, P.O. Box 522, 11001 Belgrade, Serbia.
700    1_
$a Clairand, I $u Institut de Radioprotection et de Sûreté Nucléaire (IRSN), BP17, 92262 Fontenay-aux-Roses Cedex, France.
700    1_
$a De Angelis, C $u Istituto Superiore di Sanità (ISS), Viale Regina Elena 299, 00161 Rome, Italy.
700    1_
$a Domienik, J $u Nofer Institute of Occupational Medicine, 8 Sw. Teresy, Str., 91-348 Łódź, Poland.
700    1_
$a Jarvinen, H $u Radiation and Nuclear Safety Authority (STUK), P.O. Box 14, 00881 Helsinki, Finland.
700    1_
$a Kopec, R $u Institute of Nuclear Physics (IFJ - PAN), ul Radzikowskiego 152, PL-31-342 Kraków, Poland.
700    1_
$a Majer, M $u Ruđer Bošković Institute (RBI), Bijenička c. 54, 10000, Zagreb, Croatia.
700    1_
$a Malchair, F $u Centre Hospitalier Universitaire de Liège (CHUL)/Zephyra scrl, Avenue de l'Hôpital, 4000 Liège, Belgium.
700    1_
$a Novák, L $u National Radiation Protection Institute (NRPI), Bartoškova 28, 140 00 Prague 4, Czech Republic.
700    1_
$a Siiskonen, T $u Radiation and Nuclear Safety Authority (STUK), P.O. Box 14, 00881 Helsinki, Finland.
700    1_
$a Vanhavere, F $u Belgian Nuclear Research Centre (SCK-CEN), Boeretang 200, BE-2400 Mol, Belgium.
700    1_
$a Trianni, A $u Udine University Hospital (AOUD), pl S. Maria della Misericordia, 15, 33100 Udine, Italy.
700    1_
$a Knežević, Ž $u Ruđer Bošković Institute (RBI), Bijenička c. 54, 10000, Zagreb, Croatia.
773    0_
$w MED00167391 $t Physica medica PM an international journal devoted to the applications of physics to medicine and biology official journal of the Italian Association of Biomedical Physics (AIFB) $x 1724-191X $g Roč. 31, č. 8 (2015), s. 1112-7
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26439858 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170103 $b ABA008
991    __
$a 20170119101854 $b ABA008
999    __
$a ok $b bmc $g 1180114 $s 961541
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 31 $c 8 $d 1112-7 $e 20151004 $i 1724-191X $m Physica medica $n Phys Med $x MED00167391
LZP    __
$a Pubmed-20170103

Najít záznam

Citační ukazatele

Možnosti archivace